|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.11 USD | -0.47% |
|
-0.47% | -2.31% |
PharmaCyte Biotech, Inc. reported earnings results for the full year ended April 30, 2023. For the full year, the company reported net loss was USD 4.32 million compared to USD 4.24 million a year ago. Basic loss per share from continuing operations was USD 0.22 compared to USD 0.27 a year ago.
Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.31% | 17.84M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
PHARMACYTE BIOTECH, INC. 
